Skip to main
MXL
MXL logo

MaxLinear (MXL) Stock Forecast & Price Target

MaxLinear (MXL) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 17%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

MaxLinear Inc. has projected a sales outlook of $125 million at the midpoint, surpassing market expectations by 8% and reflecting a 15% quarter-over-quarter increase, indicative of robust revenue momentum. Additionally, the company anticipates further growth, with revenue expected to rise to $130 million and earnings per share (EPS) of $0.19 in the following quarter, bolstered by improved seasonal sales patterns. The Keystone PAM4 DSP product line is poised for significant expansion, projected to generate $35 million in 2024 and potentially double to $60–70 million in 2025, supporting a favorable long-term financial trajectory for MaxLinear.

Bears say

The financial outlook for MaxLinear Inc. is negatively impacted by expectations of reduced combined revenue due to challenges in the integration of its businesses. A significant investment risk arises from the potential slow adoption rate of the company's PAM4 solution, which could adversely affect revenue and earnings projections. Additionally, the company has suffered from foreign exchange fluctuations that reduced earnings, further complicating its financial position in the market.

MaxLinear (MXL) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 17% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MaxLinear and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MaxLinear (MXL) Forecast

Analysts have given MaxLinear (MXL) a Buy based on their latest research and market trends.

According to 6 analysts, MaxLinear (MXL) has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MaxLinear (MXL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.